Abstract 6380: PLX-4545, a selective IKZF2 degrader, reprograms suppressive Tregs leading to tumor growth inhibition and combination benefit with immune checkpoint therapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Yujun Huang, Susan Song, Linette Yang, Jianguo Ma, Jay Chung, Alejandro Dearie, Stephen Chien, Quinn Spalding, Sean Choi, Gabrielle Blanco, Julia Toth, Xiaoming Li, Gregory S. Parker, Peggy A. Thompson
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631272